Cybin
NASDAQ: HELPToronto · Founded 2019 · Ontario, Canada corporation · 3 known investors
Find your way into Cybin
143 people in our graph share verified history with the Cybin team — schools, employers, funds. One of them is your warm intro.
Mattias Ljungmanunlockedknows Eric So · together at McGill University (overlapped)
×10knows the team · via McGill University
knows the team · via University of Windsor
Helus Pharma (branded Cybin) is a clinical-stage biotech developing novel serotonergic agonist therapies for mental health conditions, with lead programs including CYB004 in Phase 2 trials for generalized anxiety disorder. The company builds proprietary drug development and delivery formulations aimed at treating psychiatric disorders.
Founders & leadership
Cybin was founded in 2019 by Eric So and Paul Glavine.
ES
Eric SoinCo-Founder & Executive ChairmanCo-founder, Executive Chairman, and Interim CEO of Cybin, a clinical-stage biotech developing serotonergic therapies for psychiatric disorders. So has held C-level roles in corporate strategy, development, and finance across public and private companies at various growth stages.
PG
Paul GlavineinCo-Founder , Director & Chief Growth OfficerPaul Glavine is Co-Founder and Chief Growth Officer at Helus Pharma (branded Cybin), a clinical-stage biotech developing serotonergic agonist therapies for mental health conditions including depression and anxiety. He also serves as Chairman of LongPoint ETFs.
GF
Gabriel FahelExecutive
GT
George TzirasinChief Business Officer
AB
Aaron BartloneinChief Operating Officer
GC
Greg CaversinChief Financial Officer
DD
Douglas DrysdaleExecutive
AI
Amir InamdarinChief Medical Officer
JP
Jacqueline PoriadjianExecutive
JK
John KanakisinCo-founder
AN
MH
Investors · 3
Reported raises · per SEC filings
Form D private placements$218M disclosed across 10 of 32 rounds · 2020–2026
▶$262KofferedSep 2026 · 4 investors · OtherRule 506(b)
▶$262KofferedSep 2026 · 4 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Eric SoExecutive Officer, Director
- Michael HalsteadExecutive Officer
- Greg CaversExecutive Officer
- Paul GlavineExecutive Officer, Director
- Gabriel FahelExecutive Officer
- Alex NivorozhkinExecutive Officer
- Aaron BartloneExecutive Officer
- George TzirasExecutive Officer
- Amir InamdarExecutive Officer
- Theresa FirestoneDirector
- Mark LawsonDirector
- Grant FroeseDirector
- Eric HoskinsDirector
- Freda Lewis-HallDirector
- Offering amount
- $262K
- First sale
- Aug 2026
- Incorporated
- Corporation, Ontario, Canada
- Federal exemptions
- 06b
▶Undisclosed amountofferedAug 2026 · 2 investors · OtherRule 506(b)
▶Undisclosed amountofferedAug 2026 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Eric SoExecutive Officer, Director
- Michael HalsteadExecutive Officer
- Greg CaversExecutive Officer
- Paul GlavineExecutive Officer, Director
- Gabriel FahelExecutive Officer
- Alex NivorozhkinExecutive Officer
- Aaron BartloneExecutive Officer
- George TzirasExecutive Officer
- Amir InamdarExecutive Officer
- Theresa FirestoneDirector
- Mark LawsonDirector
- Grant FroeseDirector
- Eric HoskinsDirector
- Freda Lewis-HallDirector
- First sale
- Aug 2026
- Incorporated
- Corporation, Ontario, Canada
- Federal exemptions
- 06b
▶Undisclosed amountofferedAug 2026 · 1 investors · OtherRule 506(b)
▶Undisclosed amountofferedAug 2026 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Eric SoExecutive Officer, Director
- Michael HalsteadExecutive Officer
- Greg CaversExecutive Officer
- Paul GlavineExecutive Officer, Director
- Gabriel FahelExecutive Officer
- Alex NivorozhkinExecutive Officer
- Aaron BartloneExecutive Officer
- George TzirasExecutive Officer
- Amir InamdarExecutive Officer
- Theresa FirestoneDirector
- Mark LawsonDirector
- Grant FroeseDirector
- Eric HoskinsDirector
- Freda Lewis-HallDirector
- First sale
- Aug 2026
- Incorporated
- Corporation, Ontario, Canada
- Federal exemptions
- 06b
▶$511.7KofferedJul 2026 · 13 investors · OtherRule 506(b)
▶$511.7KofferedJul 2026 · 13 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Eric SoExecutive Officer, Director
- George TzirasExecutive Officer
- Gabriel FahelExecutive Officer
- Paul GlavineExecutive Officer, Director
- Greg CaversExecutive Officer
- Aaron BartloneExecutive Officer
- Amir InamdarExecutive Officer
- Theresa FirestoneDirector
- Mark LawsonDirector
- Grant FroeseDirector
- Eric HoskinsDirector
- Freda Lewis-HallDirector
- Offering amount
- $511.7K
- First sale
- Jul 2026
- Incorporated
- Corporation, Ontario, Canada
- Federal exemptions
- 06b
▶Undisclosed amountofferedJul 2026 · 5 investors · OtherRule 506(b)
▶Undisclosed amountofferedJul 2026 · 5 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Eric SoExecutive Officer, Director
- George TzirasExecutive Officer
- Gabriel FahelExecutive Officer
- Paul GlavineExecutive Officer, Director
- Greg CaversExecutive Officer
- Aaron BartloneExecutive Officer
- Amir InamdarExecutive Officer
- Theresa FirestoneDirector
- Mark LawsonDirector
- Grant FroeseDirector
- Eric HoskinsDirector
- Freda Lewis-HallDirector
- First sale
- Jul 2026
- Incorporated
- Corporation, Ontario, Canada
- Federal exemptions
- 06b
▶Undisclosed amountofferedMar 2026 · 1 investors · OtherRule 506(b)
▶Undisclosed amountofferedMar 2026 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Theresa FirestoneDirector
- Gabriel FahelExecutive Officer
- Mark LawsonDirector
- Grant FroeseDirector
- George TzirasExecutive Officer
- Paul GlavineDirector, Executive Officer
- Michael ColaExecutive Officer
- Eric HoskinsDirector
- Eric SoDirector, Executive Officer
- Greg CaversExecutive Officer
- Aaron BartloneExecutive Officer
- First sale
- Mar 2026
- Incorporated
- Corporation, Ontario, Canada
- Federal exemptions
- 06b
▶$114.2KofferedJan 2026 · 3 investors · OtherRule 506(b)
▶$114.2KofferedJan 2026 · 3 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Eric HoskinsDirector
- Theresa FirestoneDirector
- Gabriel FahelExecutive Officer
- Aaron BartloneExecutive Officer
- Greg CaversExecutive Officer
- Grant FroeseDirector
- Eric SoDirector, Executive Officer
- Paul GlavineDirector, Executive Officer
- George TzirasExecutive Officer
- Mark LawsonDirector
- Offering amount
- $114.2K
- First sale
- Dec 2025
- Incorporated
- Corporation, Ontario, Canada
- Federal exemptions
- 06b
▶$288.6KofferedNov 2025 · 5 investors · OtherRule 506(b)
▶$288.6KofferedNov 2025 · 5 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Eric SoDirector, Executive Officer
- Aaron BartloneExecutive Officer
- Eric HoskinsDirector
- George TzirasExecutive Officer
- Greg CaversExecutive Officer
- Mark LawsonDirector
- Theresa FirestoneDirector
- Paul GlavineDirector, Executive Officer
- Gabriel FahelExecutive Officer
- Grant FroeseDirector
- Offering amount
- $288.6K
- First sale
- Nov 2025
- Incorporated
- Corporation, Ontario, Canada
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
3 people who came through Cybin went on to found or lead other companies.
In the news
3 Revenue Generating Psychedelics Stocks Retail Investors Are Screening Right Nowfinance.yahoo.com · Aug 2026Frequently asked questions
- What does Cybin do?
- Helus Pharma (branded Cybin) is a clinical-stage biotech developing novel serotonergic agonist therapies for mental health conditions, with lead programs including CYB004 in Phase 2 trials for generalized anxiety disorder. The company builds proprietary drug development and delivery formulations aimed at treating psychiatric disorders.
- Who founded Cybin?
- Cybin was founded by Eric So, Paul Glavine in 2019.
- Who are Cybin's investors?
- Cybin's investors include Innovating Capital, JLS, Noetic.
- How much funding has Cybin raised?
- Cybin has disclosed $218M raised across 10 of its 32 known rounds.
- Where is Cybin headquartered?
- Cybin is headquartered in Toronto.